Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schattenberg

Showing results (311-320 of 333) with videos related to

Pageof 34
Sort By:
Gut|March 2, 2026
Colorectal cancer in metabolic dysfunction-associated steatotic liver disease: an international Delphi consensus statementChu-Tian Wu, Giovanni Targher, Christopher D Byrne, et al.
Nature Communications|September 26, 2024
Decoding the diagnostic and therapeutic potential of microbiota using pan-body pan-disease microbiomicsGeorges P Schmartz, Jacqueline Rehner, Madline P Gund, et al.
Journal of Hepatology|December 23, 2021
Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver diseaseOlivier Govaere, Sine Kragh Petersen, Nuria Martinez-Lopez, et al.
Hepatology (Baltimore, Md.)|August 4, 2023
A global action agenda for turning the tide on fatty liver diseaseJeffrey V Lazarus, Henry E Mark, Alina M Allen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 10, 2025
Global Burden of Major Chronic Liver Diseases in 2021Gong Feng, Yusuf Yilmaz, Luca Valenti, et al.
Journal of Hepatology|June 23, 2023
A global research priority agenda to advance public health responses to fatty liver diseaseJeffrey V Lazarus, Henry E Mark, Alina M Allen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 10, 2025
Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data From Nine CountriesZobair M Younossi, James M Paik, Jeffrey V Lazarus, et al.
The American Journal of Gastroenterology|January 3, 2025
Global, Regional, and National Burden of Primary Liver Cancer Attributable to Metabolic Risks: An Analysis of the Global Burden of Disease Study 1990-2021Chutian Wu, Giovanni Targher, Christopher D Byrne, et al.
Gastroenterology|April 13, 2025
Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and SteatohepatitisZobair M Younossi, Shira Zelber-Sagi, Jeffrey V Lazarus, et al.
BMC Public Health|July 19, 2022
LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countriesIsabel Graupera, Maja Thiele, Ann T Ma, et al.
Pageof 34

Showing results (311-320 of 333) with videos related to

Sort By:
Pageof 34
Gut|March 2, 2026
Colorectal cancer in metabolic dysfunction-associated steatotic liver disease: an international Delphi consensus statementChu-Tian Wu, Giovanni Targher, Christopher D Byrne, et al.
Nature Communications|September 26, 2024
Decoding the diagnostic and therapeutic potential of microbiota using pan-body pan-disease microbiomicsGeorges P Schmartz, Jacqueline Rehner, Madline P Gund, et al.
Journal of Hepatology|December 23, 2021
Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver diseaseOlivier Govaere, Sine Kragh Petersen, Nuria Martinez-Lopez, et al.
Hepatology (Baltimore, Md.)|August 4, 2023
A global action agenda for turning the tide on fatty liver diseaseJeffrey V Lazarus, Henry E Mark, Alina M Allen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 10, 2025
Global Burden of Major Chronic Liver Diseases in 2021Gong Feng, Yusuf Yilmaz, Luca Valenti, et al.
Journal of Hepatology|June 23, 2023
A global research priority agenda to advance public health responses to fatty liver diseaseJeffrey V Lazarus, Henry E Mark, Alina M Allen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 10, 2025
Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data From Nine CountriesZobair M Younossi, James M Paik, Jeffrey V Lazarus, et al.
The American Journal of Gastroenterology|January 3, 2025
Global, Regional, and National Burden of Primary Liver Cancer Attributable to Metabolic Risks: An Analysis of the Global Burden of Disease Study 1990-2021Chutian Wu, Giovanni Targher, Christopher D Byrne, et al.
Gastroenterology|April 13, 2025
Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and SteatohepatitisZobair M Younossi, Shira Zelber-Sagi, Jeffrey V Lazarus, et al.
BMC Public Health|July 19, 2022
LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countriesIsabel Graupera, Maja Thiele, Ann T Ma, et al.
Pageof 34